1. Home
  2. RECT vs ANTX Comparison

RECT vs ANTX Comparison

Compare RECT & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rectitude Holdings Ltd

RECT

Rectitude Holdings Ltd

N/A

Current Price

$1.67

Market Cap

26.1M

Sector

N/A

ML Signal

N/A

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$1.17

Market Cap

31.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RECT
ANTX
Founded
1997
2017
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.1M
31.2M
IPO Year
2024
2022

Fundamental Metrics

Financial Performance
Metric
RECT
ANTX
Price
$1.67
$1.17
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$2.00
AVG Volume (30 Days)
8.6K
134.3K
Earning Date
02-20-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.12
N/A
Revenue
$32,594,177.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$14.35
N/A
Revenue Growth
5.91
N/A
52 Week Low
$1.50
$1.00
52 Week High
$6.43
$1.55

Technical Indicators

Market Signals
Indicator
RECT
ANTX
Relative Strength Index (RSI) 43.09 51.99
Support Level $1.58 $1.15
Resistance Level $1.90 $1.28
Average True Range (ATR) 0.10 0.10
MACD 0.01 -0.00
Stochastic Oscillator 30.82 45.47

Price Performance

Historical Comparison
RECT
ANTX

About RECT Rectitude Holdings Ltd

Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, hand gloves, safety footwear, and personal fall arrest systems (a system used to arrest an employee in a fall from a walking-working surface, usually consisting of a body harness, anchorage, and connector), portable fire extinguishers and traffic products such as rubber speed humps, wheel stops and wheel chocks. Additionally the company has added auxiliary products such as industrial hardware tools and electrical hardware required for construction sites.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.

Share on Social Networks: